We are live on ! Find out more
TCOV

Trust Company of Vermont Portfolio holdings

AUM $2.68B
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.2B
AUM Growth
+$42.5M
Cap. Flow
+$2.61M
Cap. Flow %
0.22%
Top 10 Hldgs %
19.99%
Holding
1,087
New
93
Increased
215
Reduced
205
Closed
49

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$1.6M
2
BND icon
Vanguard Total Bond Market
BND
+$1.2M
3
MSM icon
MSC Industrial Direct
MSM
+$832K
4
AMAT icon
Applied Materials
AMAT
+$793K
5
JPM icon
JPMorgan Chase
JPM
+$775K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$1.18M
2
DD icon
DuPont de Nemours
DD
+$810K
3
FDX icon
FedEx
FDX
+$681K
4
XOM icon
ExxonMobil
XOM
+$545K
5
WFC icon
Wells Fargo
WFC
+$517K

Sector Composition

Rank Sector Weight
1 Technology 13.39%
2 Financials 13.27%
3 Healthcare 13.2%
4 Industrials 11.18%
5 Consumer Staples 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RYAM icon
951
Rayonier Advanced Materials
RYAM
$561M
$1K ﹤0.01%
133
– –
SCHE icon
952
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
$1K ﹤0.01%
25
– –
TDC icon
953
Teradata
TDC
$2.49B
$1K ﹤0.01%
33
– –
TNL icon
954
Travel + Leisure Co
TNL
$4.58B
$1K ﹤0.01%
29
– –
TPST icon
955
Tempest Therapeutics
TPST
$19.3M
– –
0
– –
TRIP icon
956
TripAdvisor
TRIP
$1.26B
$1K ﹤0.01%
21
– –
TTD icon
957
Trade Desk
TTD
$6.34B
$1K ﹤0.01%
50
– –
MDP
958
DELISTED
Meredith Corporation
MDP
$1K ﹤0.01%
10
– –
CHK
959
DELISTED
Chesapeake Energy Corporation
CHK
$1K ﹤0.01%
4
– –
JCP
960
DELISTED
J.C. Penney Company, Inc.
JCP
$1K ﹤0.01%
700
– –
AEG icon
961
Aegon
AEG
$13.9B
– –
-391
Closed -$2K
AGIO icon
962
Agios Pharmaceuticals
AGIO
$2.04B
– –
-18
Closed -$1K
ARMK icon
963
Aramark
ARMK
$15.9B
– –
-970
Closed -$21K
ATNM icon
964
Actinium Pharmaceuticals
ATNM
$25.8M
$0 ﹤0.01%
+50
New +$502
BFH icon
965
Bread Financial
BFH
$4.46B
– –
-93
Closed -$13K
CADE
966
DELISTED
Cadence Bank
CADE
– –
-78
Closed -$2K
CGNX icon
967
Cognex
CGNX
$10.2B
– –
-19
Closed -$1K
VISN
968
Vistance Networks Inc
VISN
$2.67B
– –
-72
Closed -$2K
COTY icon
969
Coty
COTY
$2.43B
– –
-88
Closed -$1K
DAN icon
970
Dana Inc
DAN
$3.2B
– –
-85
Closed -$2K
KYNB
971
Kyntra Bio
KYNB
$28.7M
– –
-1
Closed -$1K
FIBK icon
972
First Interstate BancSystem
FIBK
$3.67B
– –
-77
Closed -$3K
FOLD
973
DELISTED
Amicus Therapeutics
FOLD
– –
-70
Closed -$1K
FTNT icon
974
Fortinet
FTNT
$118B
– –
-100
Closed -$2K
FWONA icon
975
Liberty Media Series A
FWONA
$23.7B
$0 ﹤0.01%
+11
New +$384
37 38
39
40 41

Similar funds

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
TCAM
Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return

Trust Company of Vermont's Q2 2019 Portfolio in Review

As of Q2 2019, Trust Company of Vermont held 1,087 positions worth $1.2B, up 3.7% from $1.16B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trust Company of Vermont's Q2 2019 filing shows 93 new, 215 increased, 205 reduced and 49 closed positions. Its largest new stake was Dow Inc: 12,586 shares worth $620K. The largest sale was Novartis, an estimated $1.18M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Trust Company of Vermont's largest Q2 2019 buy was Dow Inc: 12,586 shares worth $620K.
  • Trust Company of Vermont added most to CVS Health in Q2 2019, an estimated $1.6M increase.
  • Trust Company of Vermont's biggest Q2 2019 reduction was Novartis, cutting an estimated $1.18M.
  • Trust Company of Vermont fully exited Bemis in Q2 2019, selling an estimated $353K.
  • Trust Company of Vermont's ten largest holdings make up 20% of its $1.2B portfolio in Q2 2019.
  • Trust Company of Vermont opened 93 new positions and closed 49 in Q2 2019.
  • Trust Company of Vermont's portfolio value rose 3.7% quarter-over-quarter to $1.2B.

Based on Trust Company of Vermont's 13F filing for Q2 2019, filed 26 Jul 2019.